Beckers Hospital Review

JULY 28, 2025

These drugs make a huge difference in outcomes for patients, but they are not as familiar with the concept as they are with chemotherapy. Likewise, and disappointingly, medical schools seem quite behind. Early residents don’t seem to have learned about these drugs consistently in medical school.

Medical Schools

Pharmacy Times

JUNE 19, 2025

1 Biomarker testing is relatively new in the treatment landscape for NSCLC but has proven incredibly important for personalizing patient care, transforming from a generic chemotherapy approach to a highly personalized, genomically driven treatment strategy. For advanced disease, chemotherapy was the standard.

Chemotherapy

European Pharmaceutical Review

DECEMBER 28, 2023

As a result, when the patient’s lymphoma relapses after treatment with chemotherapy, BV and CPIs, there are no effective treatment alternatives for these patients. at the Hannover Medical School, Germany, and spent his career as a practicing oncologist. Dr Harstrick received his M.D.

Immunization

European Pharmaceutical Review

DECEMBER 27, 2023

Bridging therapy has been shown to correlate with an inferior response to CAR T-cell therapy due to both progression of the chemotherapy-refractory malignant disease during the manufacturing period and increased toxicity. References Liu D.

Adverse Reactions

European Pharmaceutical Review

MAY 23, 2024

Imran holds an MD from Rutgers New Jersey Medical School and a PhD in Physiology and Biophysics with a dissertation focus on Hematology/Oncology from Albert Einstein College of Medicine. 2 CAR-T can be helpful in treating some types of cancer, even when other treatments are no longer working. References National Cancer Institute.

Medical Schools

STAT

JULY 24, 2023

But other cancers have also increased in many countries, said Dr. Tomotaka Ugai, an instructor at Harvard Medical School who led the research. Gosline started a chemotherapy regimen that involves eight weeks of infusions followed by a four-week break.

Medical Schools

pharmaphorum

JUNE 7, 2022

For decades, cancer treatment was often a one-size-fits-all approach that involved invasive surgery and the use of toxic chemotherapy. Steven graduated from Edinburgh Medical School and spent a number of years working for the NHS before joining the industry. Exact Sciences’ work across the cancer continuum. About Exact Sciences.

Chemotherapy